Endothelial dysfunction biomarker, endothelial cell-specific molecule-1, and pediatric metabolic syndrome

HALICI, Iclal; Palabiyik, Saziye Sezin; Güdücü Tüfekci, Fatma; OZBEK-BILGIN, Asli; Çayır, Atilla

doi:10.1111/ped.12989

Makale Tam Makale Uluslararası 2016

Endothelial dysfunction biomarker, endothelial cell-specific molecule-1, and pediatric metabolic syndrome

Iclal HALICI, Saziye Sezin Palabiyik, Fatma Güdücü Tüfekci, Asli OZBEK-BILGIN, Atilla Çayır

PEDIATRICS INTERNATIONAL Cilt 58 · Sayı 11 · ss. 1124–1129 · 01.11.2016

DOI ile aç

Özet

BackgroundThe aim of this study was to compare serum endothelial cell-specific molecule-1 (endocan) in pediatric patients with metabolic syndrome (MetS) and in healthy children, and to determine whether it can be used as an indicator of endothelium damage-induced complications in pediatric MetS patients.

Anahtar kelimeler

CHILDREN Young adults C-REACTIVE PROTEIN CHILDHOOD pediatric INSULIN-RESISTANCE METABOLIC SYNDROME ADIPOSE-TISSUE Cardiovascular risk factors Endocan ENDOTHELIAL DYSFUNCTION OBESE enzyme-linked immunosorbent assay HOMEOSTASIS MODEL ASSESSMENT ENDOCAN LEVELS

Atıf için künye

HALICI, I., Palabiyik, S. S., Güdücü Tüfekci, F., OZBEK-BILGIN, A., & Çayır, A. (2016). Endothelial dysfunction biomarker, endothelial cell-specific molecule-1, and pediatric metabolic syndrome. PEDIATRICS INTERNATIONAL, 58(11), 1124–1129. https://doi.org/10.1111/ped.12989

BibTeX

@article{halici2016-246726,
  author = {HALICI, Iclal and Palabiyik, Saziye Sezin and Güdücü Tüfekci, Fatma and OZBEK-BILGIN, Asli and Çayır, Atilla},
  title = {Endothelial dysfunction biomarker, endothelial cell-specific molecule-1, and pediatric metabolic syndrome},
  journal = {PEDIATRICS INTERNATIONAL},
  year = {2016},
  volume = {58},
  number = {11},
  pages = {1124--1129},
  issn = {1328-8067},
  doi = {10.1111/ped.12989},
  url = {https://akademik.atauni.edu.tr/yayinlar/246726-endothelial-dysfunction-biomarker-endothelial-cell-specific-molecule-1-and}
}